Company news
Wellnex Life Ltd (ASX:WNX) news
Wellnex Life Ltd news releases on 6ix. Latest, Aug 15, 2024: Wellnex Receives Opening Order in the UK from Haleon
Press releases — page 2
Wellnex Receives Opening Order in the UK from Haleon
August 14, 2024
Appendix 4C and Quarterly Report for Jun 2024 Quarter
July 31, 2024
Proposed issue of securities - WNX
July 24, 2024
Wellnex Raises $2m Placement and Update on LSE Dual Listing
July 24, 2024
Trading Update - June
June 30, 2024
Trading Update - May
June 12, 2024
Wellnex Launches Medicinal Cannabis Brand Wellness Life
June 4, 2024
Wellnex Re-engages CW NZ and Supplies First Pain Away Order
May 23, 2024
Business Update
May 8, 2024
Launch of Additional Wakey Wakey Products
May 7, 2024
Appendix 4C and Quarterly Report for Mar 2024 Quarter
April 30, 2024
Wellnex to Dual List on the London Stock Exchange
April 22, 2024
Reinstatement to Official Quotation
March 7, 2024
Cleansing Prospectus
March 7, 2024
UK Reg Approval for Paracetamol Soft Gel Liquid Analgesic
February 14, 2024
Distribution Agreement Signed with Elysian
February 5, 2024
Appendix 4C and Quarterly Report for Dec 2023 - Correction
January 31, 2024
Appendix 4C and Quarterly Report for Dec 2023 Quarter
January 31, 2024
WNX Signs International Distribution Agreement with Homart
January 2, 2024
Reinstatement to quotation
December 18, 2023
Reinstatement Disclosure
December 18, 2023
Completion of Pain Away Acquisition and Company Update
December 18, 2023
Successful Entitlement Offer and Pain Away Update
December 7, 2023
Results of Entitlement Offer and Shortfall Offer Open
November 30, 2023
Supplementary Prospectus
November 22, 2023
Entitlement Offer Open & Dispatch of Prospectus
November 16, 2023
$13.6m Entitlement Offer to fund Pain Away acquisition
November 12, 2023
Prospectus
November 12, 2023
Update on Pain Away Acquisition
November 3, 2023
Appendix 4C and Quarterly Report for Sep 2023 Quarter
October 31, 2023
Pain Away Acquisition Update
October 5, 2023
Update on Pain Away Transaction
September 11, 2023
Company Update on Pain Away Transaction
September 1, 2023
Amended FY23 Results Announcement
September 1, 2023
Wellnex Releases FY23 Appendix 4E & Preliminary Report
August 31, 2023
Market Update - Pain Away Transaction and Capital Raising
August 1, 2023
Appendix 4C and Quarterly Report for June 2023 Quarter
August 1, 2023
Entitlement Offier Results and Shortfall
July 25, 2023
Clarification of announcements and updated offer timetable
July 4, 2023
Wellnex Life Extends Supply Agreement with Haleon
June 28, 2023
Investor Presentation
May 25, 2023
Suspension from Official Quotation
May 22, 2023
Appendix 4C and Quarterly Report for March 2023 Quarter
April 27, 2023
Wellnex to Enter the SAS-B Medicinal Cannabis Market with CW
March 13, 2023
Pharmacy Own Products Update
February 13, 2023
Appendix 4C and Quarterly Report for December 2022 Quarter
January 23, 2023
Trading Update - Half Year Ended 31 December 2022
January 8, 2023
Completion of Mr Bright Acquisition and Trading Update
December 12, 2022
Appendix 4C and Quarterly Report for September 2022 Quarter
October 27, 2022
Strategic Placement & Successful Share Purchase Plan
October 19, 2022